ALEXANDRIA, Va. – American Society of Clinical Oncology, Inc. (ASCO®) and its wholly-owned subsidiary, QOPI Certification Program, LLC (QCP), announced today that The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, will recognize QOPI® Certification in its rate structure. Physicians participating in practices accredited by QCP’s Quality Oncology Practice Initiative (QOPI®) Certification Program will be eligible for a discount of up to 10% on medical malpractice insurance from The Doctors Company.
“We commend The Doctors Company for its recognition of QOPI Certification as a mark of excellence in quality cancer care,” said ASCO CEO Allen S. Lichter, MD, FASCO. “QOPI Certification demonstrates a practice’s commitment to providing the highest level of quality of care for their patients, and we are grateful to The Doctors Company for recognizing those physicians who achieve this high standard.”
“We are proud to collaborate with ASCO and QCP to recognize QOPI Certified practices that have demonstrated commitment to providing outstanding oncology care,” said Richard E. Anderson, MD, FACP, chairman and CEO of The Doctors Company. “Member programs like this support our mission to defend, protect, and reward the practice of good medicine.”
QOPI is a voluntary self-assessment and improvement program launched by ASCO in 2006 to help hematology-oncology and medical oncology practices assess the quality of the care they provide to patients. Through QOPI, practices abstract data from patients’ records up to twice per year and enter this information into a secure database. More than 900 oncology practices have registered for QOPI to date, and 250 have received their QOPI Certification through QCP.
QCP is an ASCO affiliate dedicated to innovative quality improvement programs for ASCO members and their patients and is committed to providing oncologists with the necessary resources to provide every patient with high-level cancer care. Its flagship program, the QOPI Certification Program, launched in 2010, is the first program of its kind for oncology in the United States. To become certified, practices must submit to an evaluation of their entire practice as well as their documentation standards. Through onsite inspections, staff and steering group members then verify that the evaluation and documents are correct and that the practices meet core standards in key areas of treatment, including:
- treatment planning;
- staff training and education;
- chemotherapy orders and drug preparation;
- patient consent and education;
- safe chemotherapy administration; and
- monitoring and assessment of patient well-being.
The Doctors Company will offer up to a 10% discount to physicians whose outpatient hematology-oncology practices have successfully received the three-year QOPI Certification through QCP. Physicians in QOPI Certified practices are now able to apply for this discount, which will take effect for eligible practices at the time of their next insurance renewal.
QOPI and the QCP are dedicated to innovative quality improvement. For more information, please visit: http://www.instituteforquality.org/qopi-qcp.
Founded in 1964, the American Society of Clinical Oncology (ASCO) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents more than 40,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at www.ASCO.org, explore patient education resources at www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube.
About QOPI Certification Program, LLC
QOPI Certification Program LLC is an ASCO affiliate dedicated to innovative quality improvement programs for ASCO members and their patients and is committed to providing oncologists with the necessary resources to provide every patient with high-level cancer care.